LBMC Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-345
Closed -$213K 209
2024
Q3
$213K Buy
+345
New +$204K 0.02% 182
2024
Q2
Sell
-345
Closed -$201K 192
2024
Q1
$201K Buy
+345
New +$194K 0.02% 180
2022
Q2
Sell
-357
Closed -$211K 163
2022
Q1
$211K Sell
357
-28
-7% -$16.1K 0.02% 153
2021
Q4
$257K Sell
385
-10,230
-96% -$6.39M 0.02% 146
2021
Q3
$220 Buy
+10,615
New +$5.83M 0.02% 154

Other funds holding TMO

LBMC Investment Advisors's TMO Position: Q4 2024 in Review

LBMC Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 345 shares — an estimated $213K sold.

LBMC Investment Advisors first reported a position in TMO in Q3 2021 and held it in 5 quarters. The position peaked at $257K in Q4 2021. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • LBMC Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • LBMC Investment Advisors sold 345 Thermo Fisher Scientific shares in Q4 2024, an estimated $213K.
  • LBMC Investment Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 5 quarters.
  • LBMC Investment Advisors's Thermo Fisher Scientific position peaked at $257K in Q4 2021.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on LBMC Investment Advisors's 13F filing for Q4 2024, filed 16 Jan 2025.